Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-13-001

Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)

Closed on September 20, 2013.

Posted
November 9, 2012
Close date
September 20, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
12
12 new
Median first-year cost
$231,818
$2,842,974 in all
Institutions
12
12 contact PIs
Patents
9
from 4 funded projects

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
  2. JOHNS HOPKINS UNIVERSITY1
  3. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
  4. RESEARCH INST OF FOX CHASE CAN CTR1
  5. SLOAN-KETTERING INST CAN RESEARCH1

and 7 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 SRLB-Q (M1))7
  2. Special Emphasis Panel (ZCA1 SRLB-Q (J1))5
12 awards under RFA-CA-13-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2014A novel single-molecule telomere characterization technology for analyzing cancer1R21CA177395-01A1Riethman, HaroldXiao, MingWISTAR INSTITUTE, PAFirst-year cost $304,593Study section ZCA1
FY2014Highly multiplexed ion-beam tissue RNA in situ imaging with sub-micron resolution1R21CA183660-01Borowsky, Alexander DLevenson, Richard M.UNIVERSITY OF CALIFORNIA AT DAVIS, CAFirst-year cost $275,943Study section ZCA1
FY2014Immobilized protease activity tests for developing functional cancer biomarkers.1R21CA174537-01A1Tempst, PaulSLOAN-KETTERING INST CAN RESEARCH, NYFirst-year cost $266,362Study section ZCA1
FY2014Implantable device for high-throughput in vivo drug sensitivity testing1R21CA177391-01A1Cima, Michael JMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MAFirst-year cost $258,960Study section ZCA1
FY2014Digital Detection of Tumor-Derived Circulating Methylated DNA1R21CA186809-01Wang, Tza-Huei JeffJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $243,409Study section ZCA1
FY2014A Novel Allele-Specific RNA-ISH for Differential Allele-specific Expression1R21CA186853-01Chen, XiaoweiRESEARCH INST OF FOX CHASE CAN CTR, PAFirst-year cost $232,943Study section ZCA1
FY2014A micro Hall chip for circulating microvesicle based cancer monitoring1R21CA182336-01A1Issadore, David AaronUNIVERSITY OF PENNSYLVANIA, PAFirst-year cost $230,692Study section ZCA1
FY2014Integrated Microfluidic Exosome Profiling for Early Detection of Cancer1R21CA186846-01Zeng, YongUNIVERSITY OF KANSAS LAWRENCE, KSFirst-year cost $220,833Study section ZCA1
FY2014Quantitative profiling of glycosaminoglycans from breast tumor tissue arrays1R21CA177479-01A1Zaia, JosephBOSTON UNIVERSITY MEDICAL CAMPUS, MAFirst-year cost $213,629Study section ZCA1
FY2014Ultra-Bright Probes with Ultra-Narrow Emission for Molecular and Cellular Analysi1R21CA186798-01Chiu, Daniel TUNIVERSITY OF WASHINGTON, WAFirst-year cost $201,623Study section ZCA1
FY2014Photoreactive histone deacetylase probes for chromatin immunoprecipitation in can1R21CA183627-01Frasor, JonnaPetukhov, Pavel AUNIVERSITY OF ILLINOIS AT CHICAGO, ILFirst-year cost $198,879Study section ZCA1
FY2014Molecular analysis of physical microenvironmental control of tumor cell invasion1R21CA174573-01A1Kumar, SanjayUNIVERSITY OF CALIFORNIA BERKELEY, CAFirst-year cost $195,108Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

9 patents name 4 of the 12 funded projects. The newest 5, by patent number.

  1. US 12,693,295 (opens the patent at USPTO, a PDF, in a new tab)METHODS FOR INKJET PRINTING OBJECTS FOR MICROFLUIDIC DEVICESGranted July 28, 2026 to University of KansasR21CA186846 · UNIVERSITY OF KANSAS LAWRENCE, KS
  2. US 11,774,361 (opens the patent at USPTO, a PDF, in a new tab)WAVEGUIDE-BASED SIDE-ILLUMINATION TECHNIQUE FOR MUSE MICROSCOPY AND ASSOCIATED HISTOLOGY CASSETTESGranted October 3, 2023 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR21CA183660 · UNIVERSITY OF CALIFORNIA AT DAVIS, CA
  3. US 11,761,028 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF SPECIFICALLY LABELING NUCLEIC ACIDS USING CRISPR/CASGranted September 19, 2023 to DREXEL UNIVERSITYR21CA177395 · WISTAR INSTITUTE, PA
  4. US 11,726,086 (opens the patent at USPTO, a PDF, in a new tab)GRAPHENE OXIDE-BASED NANOLAB AND METHODS OF DETECTING OF EXOSOMESGranted August 15, 2023 to University of Kansas and Kansas State University Research FoundationR21CA186846 · UNIVERSITY OF KANSAS LAWRENCE, KS
  5. US 11,630,052 (opens the patent at USPTO, a PDF, in a new tab)Ultra-High Throughput Detection Of Fluorescent Droplets Using Time Domain Encoded OptofluidicsGranted April 18, 2023 to The Trustees of the University of PennsylvaniaR21CA182336 · UNIVERSITY OF PENNSYLVANIA, PA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.